Name | Value |
---|---|
Revenues | 47.5K |
Cost of Revenue | 0.0K |
Gross Profit | 47.5K |
Operating Expense | 872.1K |
Operating I/L | -872.1K |
Other Income/Expense | -65.9K |
Interest Income | 0.0K |
Pretax | -938.0K |
Income Tax Expense | 65.9K |
Net Income/Loss | -1,003.8K |
SeqLL Inc. is a global life sciences instrumentation and research services company specializing in genetic analysis technologies. The company's true single molecule sequencing (tSMS) platform provides a unique solution for DNA and RNA sequencing. SeqLL generates revenue by designing, developing, and manufacturing these cutting-edge genetic analysis technologies. The company has established collaboration agreements with various research institutions and diagnostic companies, serving a wide range of clients including academic and government institutions, hospitals, pharmaceutical and biotechnology companies, and non-profit research organizations.